Pfizer Ltd. — Major Shareholding Notification 2025

Mar 19, 2025

भारतीय जीवन बीमा निगम

Central Office, Investment Dept., 'Yogakshema' 6^th Floor, Jeevan Bima Marg, Mumbai: 400021
Ph: 022 -66598851/ 26/38/ 47/ Fax: 22825411

Ref: Invt/Back Office

Date: 19 March 2025

To. The Company Secretary Pfizer Ltd.

1802/1901, The Capital, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (E), Mumbai, Maharashtra, 400051

Dear Sir,

Re: Disclosures under Regulation 29(2) the SEBI (Substantial Acquisition of shares and takeovers) Regulations, 2011.

We are sending herewith the disclosures as required under above mentioned SEBI regulations for a person holding more than 5% shares in a listed company. For your information we are also providing our DP IDs, Client IDs & PAN number.

Yours faithfully, ್ತ िलेश है Asstt. Secretary (Investment- Back Office) $Cc$

• 1. BSE Ltd, Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Plot no. C/1, G Block, Mumbai - 400 001.
• 1. NSE Ltd, Bandra Kurla Complex, Bandra (E), Mumbai 400 051. Encls: As above

Annexure 2

$\sim$

Format for disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Share and Takeover) Regulations, 2011

$\hat{\mathcal{A}}$

Name of the Target Company (TC)	PFIZER LTD
Name(s) of the acquirer and Persons Acting in Concert (PAC) with the Acquirer	Life Insurance Corporation of India Central Office, Yogakshema 6 th Floor, Mumbai- 400021. 022-66598626/8851
Whether the acquirer belongs to Promoter/Promoter group	NO
Name(s) of the Stock Exchange(s) where the shares of TC are Listed	NSE/BSE
Details of the acquisition / disposal/holding of shares/voting rights/holding of the Acquirer and PAC	Number	% w.r.t.total share/voting capital wherever applicable	% w.r.t. total diluted share/voting capital of the $TC$ $(*)$
Before the acquisition/disposal under consideration, holding of : a) Shares carrying voting rights b) Voting rights (VR) otherwise than by shares c) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the T C (specify holding in each category)	2768497.00	6.052%	NA
Total $(a+b+c)$	2768497.00	6.052%
Details of acquisition/sale a) Shares carrying voting rights acquired/sold b) VRs acquired /sold otherwise than by shares c) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired/sold	926730.00	2.026%
Total (a+b+c)	926730.00	2.026%

$\mathcal{L}_{\mathcal{A}}$

$\bar{\lambda}$

After the acquisition/sale, holding of:
a) Shares carrying voting rights b) VRs otherwise than by shares c) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after Acquisition.	1841767.00	4.026%
Total (a+b+c)	1841767.00	4.026%
Mode of acquisition / sale (e.g. open market / off-market / public issue / rights issue / preferential allotment / inter-se transfer etc).	MARKET SALE
Date of acquisition / sale of shares / VR or date of receipt of intimation of allotment of shares, whichever is applicable	10.05.2022-18.03.2025
Equity share capital / total voting capital of the TC before the said acquisition / sale	45,74,77,320.00
Equity share capital/ total voting capital of the TC after the said acquisition / sale	45,74,77,320.00
Total diluted share/voting capital of The TC after the said acquisition/sale.	NA

(*) Diluted share/voting capital means the total number of shares in the TC assuming full

Conversion of the outstanding convertible securities/warrants into equity shares of the

TC.

Signature of the acquirer / seller / Authorised Signatory

Place: MUMBAI

19 March 2025